{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:28:53Z","timestamp":1776468533784,"version":"3.51.2"},"reference-count":88,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1054\/blre.2000.0130","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:24Z","timestamp":1032447324000},"page":"145-156","source":"Crossref","is-referenced-by-count":21,"title":["Leucocyte depletion of blood components"],"prefix":"10.1054","volume":"14","author":[{"given":"P.H.","family":"Roddie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/blre.2000.0130_RF1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-3148.1998.00129.x","volume":"8","year":"1998","journal-title":"Transfus Med"},{"key":"10.1054\/blre.2000.0130_RF2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0887-7963(93)70125-X","article-title":"Leukodepletion blood filters: filter design and mechanisms of leukocyte removal","volume":"7","author":"Dzik","year":"1993","journal-title":"Transfus Med Rev"},{"key":"10.1054\/blre.2000.0130_RF3","series-title":"Guidelines for the Blood Transfusion Service, 4th edn","year":"2000"},{"key":"10.1054\/blre.2000.0130_RF4","series-title":"Guide to the preparation, use and quality assurance of blood components, 4th edn","year":"1997"},{"key":"10.1054\/blre.2000.0130_RF5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1423-0410.1985.tb00807.x","article-title":"Alloimmunisation to HLA antigens following transfusion with leucocyte-poor and purified platelet suspensions","volume":"49","author":"Fisher","year":"1985","journal-title":"Vox Sang"},{"key":"10.1054\/blre.2000.0130_RF6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1537-2995.1996.36196190510.x","article-title":"Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)","volume":"36","author":"Dumont","year":"1996","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1537-2995.1997.37197176948.x","article-title":"Automatic volumetric capillary cytometry for counting white cells in white cell-reduced plateletpheresis components","volume":"37","author":"Adams","year":"1997","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-3148.2000.00230.x","article-title":"Quality assurance by a commercial flow cytometry method of leucodepletion of whole blood donations: initial application of universal testing and proposals for a batch-release sampling plan","volume":"10","author":"Barclay","year":"2000","journal-title":"Transfus Med"},{"key":"10.1054\/blre.2000.0130_RF9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1423-0410.1994.tb00272.x","article-title":"Multicenter evaluation of methods for counting residual white cells in leukocyte-depleted red blood cells. The Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion","volume":"66","author":"Rebulla","year":"1994","journal-title":"Vox Sang"},{"key":"10.1054\/blre.2000.0130_RF10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1365-2141.1999.01530.x","article-title":"Preliminary assessment of whole-blood, red-cell and platelet- leucodepleting filters for possible induction of prion release by leucocyte fragmentation during room temperature processing","volume":"106","author":"Prowse","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0130_RF11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-2141.1999.01789.x","article-title":"Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry","volume":"107","author":"Barclay","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0130_RF12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1537-2995.1998.38998408999.x","article-title":"The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy","volume":"38","author":"Brown","year":"1998","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1537-2995.1999.39111169.x","article-title":"Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explantion of why blood components do not transmit Creutzfeldt-Jakob disease in humans","volume":"39","author":"Brown","year":"1999","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1423-0410.1999.7720088.x","article-title":"Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components","volume":"77","author":"MacGregor","year":"1999","journal-title":"Vox Sang"},{"key":"10.1054\/blre.2000.0130_RF15","first-page":"84","article-title":"Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension","volume":"9","author":"Claas","year":"1981","journal-title":"Exp Hematol"},{"key":"10.1054\/blre.2000.0130_RF16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood.V85.3.824.bloodjournal853824","article-title":"Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study","volume":"85","author":"Sintnicolaas","year":"1995","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0130_RF17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V77.1.201.201","article-title":"Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial","volume":"77","author":"van Marwijk","year":"1991","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0130_RF18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0887-7963(90)70237-4","article-title":"The challenge of platelet alloimmunization: management and prevention","volume":"4","author":"Kickler","year":"1990","journal-title":"Transfus Med Rev"},{"key":"10.1054\/blre.2000.0130_RF19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00062752-199502060-00015","article-title":"Causes of refractoriness to platelet transfusion","volume":"2","author":"Friedberg","year":"1995","journal-title":"Curr Opin Hematol"},{"key":"10.1054\/blre.2000.0130_RF20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0887-7963(94)70094-8","article-title":"The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies","volume":"8","author":"Heddle","year":"1994","journal-title":"Transfus Med Rev"},{"key":"10.1054\/blre.2000.0130_RF21","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood.V83.10.3028.3028","article-title":"Bedside filtration of blood products in the prevention of HLA alloimmunization\u2013a prospective randomized study. Alloimmunisation Study Group","volume":"83","author":"Williamson","year":"1994","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0130_RF22","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0130_RF23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2141.1993.tb03140.x","article-title":"Impact of leucocyte-depleted blood components on the haematological recovery and prognosis of patients with acute myeloid leukaemia. Finnish Leukemia Group","volume":"84","author":"Oksanen","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0130_RF24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.V86.1.409.bloodjournal861409","article-title":"Wider benefits of leukodepletion of blood products","volume":"86","author":"Copplestone","year":"1995","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0130_RF25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1537-2995.1993.33893342749.x","article-title":"Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia","volume":"33","author":"Balducci","year":"1993","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF26","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"A multicenter randomized study of the threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia","volume":"337","author":"Rebulla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0130_RF27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1537-2995.1993.331094054613.x","article-title":"A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions","volume":"33","author":"Heddle","year":"1993","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199409083311001","article-title":"The role of the plasma from platelet concentrates in transfusion reactions","volume":"331","author":"Heddle","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0130_RF29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1537-2995.1993.33393174443.x","article-title":"Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions","volume":"33","author":"Muylle","year":"1993","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1537-2995.1999.39399219278.x","article-title":"A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets","volume":"39","author":"Heddle","year":"1999","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF31","first-page":"233","article-title":"Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group","volume":"13","author":"McCann","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1054\/blre.2000.0130_RF32","first-page":"1","article-title":"Long-term platelet support of patients with aplastic anemia","volume":"73","author":"Grumet","year":"1970","journal-title":"Effect of splenectomy and steroid therapy. Ann Intern Med"},{"key":"10.1054\/blre.2000.0130_RF33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2141.1997.812721.x","article-title":"Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia","volume":"97","author":"Killick","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1054\/blre.2000.0130_RF34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2141.1990.tb06375.x","article-title":"Pretransfused patients with severe aplastic anaemia exhibit high numbers of cytotoxic T lymphocyte precursors probably directed at non-HLA antigens","volume":"76","author":"Kaminski","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0130_RF35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0889-8588(18)30117-5","article-title":"Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy","volume":"9","author":"Bordin","year":"1995","journal-title":"Hematology \u2013 Oncology Clinics of North America"},{"key":"10.1054\/blre.2000.0130_RF36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/bjs.1800790613","article-title":"Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery","volume":"79","author":"Jensen","year":"1992","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2000.0130_RF37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/bjs.1800830727","article-title":"A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery","volume":"83","author":"Jensen","year":"1996","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2000.0130_RF38","first-page":"253","article-title":"Effect of blood transfusions on subsequent kidney transplants","volume":"5","author":"Opelz","year":"1973","journal-title":"Transplant Proc"},{"key":"10.1054\/blre.2000.0130_RF39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/00007890-199704150-00010","article-title":"Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients","volume":"63","author":"Opelz","year":"1997","journal-title":"Transplantation"},{"key":"10.1054\/blre.2000.0130_RF40","first-page":"381","article-title":"Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course","volume":"7","author":"Lee","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1054\/blre.2000.0130_RF41","first-page":"704","article-title":"The initial immune response to HIV and immune system activation determine the outcome of HIV disease","volume":"4","author":"Sheppard","year":"1991","journal-title":"J Acquire Immune Defic Syndr"},{"key":"10.1054\/blre.2000.0130_RF42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199503023320904","article-title":"Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study","volume":"332","author":"Kovacs","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0130_RF43","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.V86.3.1082.bloodjournal8631082","article-title":"Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination","volume":"86","author":"O\u2019Brien","year":"1995","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0130_RF44","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood.V80.8.2128.2128","article-title":"Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients","volume":"80","author":"Busch","year":"1992","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0130_RF45","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1537-2995.1996.361097017169.x","article-title":"The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview","volume":"36","author":"Busch","year":"1996","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF46","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1537-2995.1995.35996029162.x","article-title":"Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation","volume":"35","author":"Vamvakas","year":"1995","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF47","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM199305133281902","article-title":"Blood transfusions and prognosis in colorectal cancer","volume":"328","author":"Busch","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0130_RF48","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1200\/JCO.1994.12.9.1859","article-title":"Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery","volume":"12","author":"Heiss","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1054\/blre.2000.0130_RF49","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(94)91965-8","article-title":"Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer","volume":"344","author":"Houbiers","year":"1994","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0130_RF50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2168.1998.00698.x","article-title":"Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies","volume":"85","author":"McAlister","year":"1998","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2000.0130_RF51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1537-2995.1996.36296181932.x","article-title":"Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials","volume":"36","author":"Vamvakas","year":"1996","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1537-2995.1999.39070718.x","article-title":"The effect of unmodified or prestorage white cell-reduced allogeneic red cell transfusions on the immune responsiveness in orthopedic surgery patients","volume":"39","author":"Bordin","year":"1999","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF53","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1537-2995.1999.39070694.x","article-title":"Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair","volume":"39","author":"Carson","year":"1999","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1537-2995.1999.39070701.x","article-title":"Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells","volume":"39","author":"Vamvakas","year":"1999","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF55","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(94)92660-3","article-title":"Autologous blood and infections after colorectal surgery","volume":"343","author":"Busch","year":"1994","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0130_RF56","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/0140-6736(93)92247-Q","article-title":"Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery","volume":"342","author":"Heiss","year":"1993","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0130_RF57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1537-2995.1997.37297203513.x","article-title":"Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study","volume":"37","author":"Houbiers","year":"1997","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/bjs.1800790613","article-title":"Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery","volume":"79","author":"Jensen","year":"1992","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2000.0130_RF59","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(96)06168-5","article-title":"Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery","volume":"348","author":"Jensen","year":"1996","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0130_RF60","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0002-9610(98)00245-1","article-title":"Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery","volume":"176","author":"Tartter","year":"1998","journal-title":"Am J Surg"},{"key":"10.1054\/blre.2000.0130_RF61","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.97.6.562","article-title":"Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial","volume":"97","author":"van de Watering","year":"1998","journal-title":"Circulation"},{"key":"10.1054\/blre.2000.0130_RF62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1537-2995.1999.39070665.x","article-title":"Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?","volume":"39","author":"Blajchman","year":"1999","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0955-3886(98)00060-5","article-title":"Potential clinical benefits and cost savings of universal leucocyte-depletion of blood components","volume":"19","author":"Murphy","year":"1998","journal-title":"Transfus Sci"},{"key":"10.1054\/blre.2000.0130_RF64","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00062752-199704060-00015","article-title":"Transfusion-associated graft-versus-host disease","volume":"4","author":"Orlin","year":"1997","journal-title":"Curr Opin Hematol"},{"key":"10.1054\/blre.2000.0130_RF65","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/00000542-199312000-00034","article-title":"Transfusion-associated graft-versus-host disease caused by leukocyte-filtered stored blood","volume":"79","author":"Hayashi","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1054\/blre.2000.0130_RF66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-116-1-55","article-title":"Reducing the risk for transfusion-transmitted cytomegalovirus infection","volume":"116","author":"Sayers","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1054\/blre.2000.0130_RF67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0887-7963(99)80084-4","article-title":"Transfusion of the HIV-seropositive patient: immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4), CMV (HHV-5), and HHV-6, 7, and 8","volume":"13","author":"Hillyer","year":"1999","journal-title":"Transfus Med Rev"},{"key":"10.1054\/blre.2000.0130_RF68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-3148.1999.00193.x","article-title":"Prevention of transfusion-transmitted cytomegalovirus infection","volume":"9","author":"Pamphilon","year":"1999","journal-title":"Transfus Med"},{"key":"10.1054\/blre.2000.0130_RF69","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","article-title":"A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant","volume":"86","author":"Bowden","year":"1995","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0130_RF70","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1537-2995.1994.34694295061.x","article-title":"Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1","volume":"34","author":"Donegan","year":"1994","journal-title":"Transfusion"},{"key":"10.1054\/blre.2000.0130_RF71","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1423-0410.1984.tb00083.x","article-title":"A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients","volume":"46","author":"Okochi","year":"1984","journal-title":"Vox Sang"},{"key":"10.1054\/blre.2000.0130_RF72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.2655084","article-title":"High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans","volume":"244","author":"Lee","year":"1989","journal-title":"Science"},{"key":"10.1054\/blre.2000.0130_RF73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0887-7963(99)80057-1","article-title":"Screening of blood donations for HTLV-I\/II","volume":"13","author":"Courouce","year":"1999","journal-title":"Transfus Med Rev"},{"key":"10.1054\/blre.2000.0130_RF74","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/39057","article-title":"Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent","volume":"389","author":"Bruce","year":"1997","journal-title":"Nature"},{"key":"10.1054\/blre.2000.0130_RF75","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/383685a0","article-title":"Molecular analysis of prion strain variation and the aetiology of \u2018new variant\u2019 CJD","volume":"383","author":"Collinge","year":"1996","journal-title":"Nature"},{"key":"10.1054\/blre.2000.0130_RF76","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/38925","article-title":"The same prion strain causes vCJD and BSE","volume":"389","author":"Hill","year":"1997","journal-title":"Nature"},{"key":"10.1054\/blre.2000.0130_RF77","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2141.1999.01457.x","article-title":"The impact of new-variant Creutzfeldt-Jakob disease on blood transfusion practice","volume":"106","author":"Turner","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0130_RF78","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0037-1615387","article-title":"Retrospective neuropathological review of prion disease in UK haemophilic patients","volume":"80","author":"Lee","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2000.0130_RF79","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(90)90225-4","article-title":"Cellular isoform of the scrapie agent protein participates in lymphocyte activation","volume":"61","author":"Cashman","year":"1990","journal-title":"Cell"},{"key":"10.1054\/blre.2000.0130_RF80","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V91.5.1556","article-title":"Prion protein expression in human leukocyte differentiation","volume":"91","author":"Dodelet","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0130_RF81","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1365-2141.1998.01032.x","article-title":"Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets","volume":"103","author":"Holada","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0130_RF82","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1006\/bbrc.1996.0936","article-title":"PrP27\u201330 is a normal soluble prion protein fragment released by human platelets","volume":"223","author":"Perini","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1054\/blre.2000.0130_RF83","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(96)91128-9","article-title":"Prion protein released by platelets","volume":"347","author":"Perini","year":"1996","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0130_RF84","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(98)24035-9","article-title":"Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease","volume":"352","author":"Hilton","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0130_RF85","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(98)12075-5","article-title":"Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples","volume":"353","author":"Hill","year":"1999","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0130_RF86","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00062752-199502060-00012","article-title":"Can Creutzfeldt-Jakob disease be transmitted by transfusion?","volume":"2","author":"Brown","year":"1995","journal-title":"Curr Opin Hematol"},{"key":"10.1054\/blre.2000.0130_RF87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/385197a0","article-title":"Predicting the CJD epidemic in humans","volume":"385","author":"Cousens","year":"1997","journal-title":"Nature"},{"key":"10.1054\/blre.2000.0130_RF88","article-title":"Assessment of the risk of exposure to vCJD infectivity in blood and blood products","author":"Comer","year":"1999","journal-title":"De Norske Veritas Final Report, Job No 8288"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X00901309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X00901309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T21:43:26Z","timestamp":1581025406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X00901309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0268960X00901309"],"URL":"https:\/\/doi.org\/10.1054\/blre.2000.0130","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}